ATE109006T1 - Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen. - Google Patents

Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.

Info

Publication number
ATE109006T1
ATE109006T1 AT91901458T AT91901458T ATE109006T1 AT E109006 T1 ATE109006 T1 AT E109006T1 AT 91901458 T AT91901458 T AT 91901458T AT 91901458 T AT91901458 T AT 91901458T AT E109006 T1 ATE109006 T1 AT E109006T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
treat
composition intended
retroviral infections
arg
Prior art date
Application number
AT91901458T
Other languages
English (en)
Inventor
Bruno Guy
Jean-Pierre Lecocq
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9013102A external-priority patent/FR2668065B1/fr
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE109006T1 publication Critical patent/ATE109006T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
AT91901458T 1989-12-18 1990-12-18 Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen. ATE109006T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8916726 1989-12-18
FR9013102A FR2668065B1 (fr) 1990-10-23 1990-10-23 Composition pharmaceutique destinee au traitement et a la prevention des infections retrovirales.

Publications (1)

Publication Number Publication Date
ATE109006T1 true ATE109006T1 (de) 1994-08-15

Family

ID=26227737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91901458T ATE109006T1 (de) 1989-12-18 1990-12-18 Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.

Country Status (8)

Country Link
EP (1) EP0506769B1 (de)
JP (1) JPH05502868A (de)
AT (1) ATE109006T1 (de)
AU (2) AU644621B2 (de)
CA (1) CA2071972A1 (de)
DE (1) DE69011130T2 (de)
DK (1) DK0506769T3 (de)
WO (1) WO1991008769A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3604093A (en) * 1992-02-07 1993-09-03 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of 5,5'-dithio-bis(2-nitrobenzoic acid) for inhibition of HIV protease
DE69333270T2 (de) 1992-03-11 2004-08-05 Narhex Ltd. Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
WO1993018006A1 (en) * 1992-03-11 1993-09-16 Narhex Limited Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
KR100273620B1 (ko) * 1992-09-09 2000-12-15 스티븐 엠. 오드리 레트로바이러스 감염의 억제방법
FR2778851B1 (fr) * 1998-05-19 2002-07-26 Aetsrn Composition a base d'inhibiteurs de cysteine-proteases pour retarder la senescence, l'autodestruction et l'hemolyse des erythrocytes
WO2005011649A2 (en) * 2003-05-19 2005-02-10 Vanderbilt University Methods of treating severe acute respiratory syndrome virus infections
US8232240B2 (en) 2005-02-23 2012-07-31 The Brigham And Women's Hospital, Inc. Inhibitors of enveloped virus infectivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43397B (en) * 1985-01-16 1989-06-30 Inst Jozef Stefan Process for insulation of poultry eggs cystatine from egg-white
EP0269311A3 (de) * 1986-11-17 1990-06-06 Merck & Co. Inc. Methoden zur Behandlung von Knochenleiden mittels Verabreichung von Cystein-Proteinaseinhibitoren

Also Published As

Publication number Publication date
WO1991008769A1 (fr) 1991-06-27
CA2071972A1 (fr) 1991-06-19
DE69011130T2 (de) 1995-03-16
EP0506769A1 (de) 1992-10-07
AU644621B2 (en) 1993-12-16
JPH05502868A (ja) 1993-05-20
DK0506769T3 (da) 1994-11-28
EP0506769B1 (de) 1994-07-27
DE69011130D1 (de) 1994-09-01
AU6975591A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
ES2145913T3 (es) Inhibidores de metaloproteasas.
DE68919358T2 (de) Zusammensetzung zur behandlung der schizophrenie.
DE69531944D1 (de) Neue hiv-protease-inhibitoren
DE69116380T2 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
BR0014465A (pt) 1,1'-bifenil-2-carbonamidas 2'-substituìdas, processos para a sua preparação,seu emprego como medicamento bem como os preparados farmacêuticos contendo as mesmas
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
ATE109006T1 (de) Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
DE69522702D1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
GB9930768D0 (en) Composition
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
ATE5796T1 (de) Pharmazeutische zusammensetzung mit gehalt an l- alpha-methyl-3,4-dihydroxyphenylalanin und salicylamid zur behandlung hohen blutdrucks.
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.
DE69022027T2 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
GT199400048A (es) Composicion farmaceutica y proceso para su preparacion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee